DK0886679T3 - Parakoppevira indeholdende fremmed DNA, fremstilling heraf og deres anvendelse i vacciner - Google Patents

Parakoppevira indeholdende fremmed DNA, fremstilling heraf og deres anvendelse i vacciner

Info

Publication number
DK0886679T3
DK0886679T3 DK97904453T DK97904453T DK0886679T3 DK 0886679 T3 DK0886679 T3 DK 0886679T3 DK 97904453 T DK97904453 T DK 97904453T DK 97904453 T DK97904453 T DK 97904453T DK 0886679 T3 DK0886679 T3 DK 0886679T3
Authority
DK
Denmark
Prior art keywords
vaccines
preparation
paracobal
foreign dna
containing foreign
Prior art date
Application number
DK97904453T
Other languages
English (en)
Inventor
Norbert Schmeer
Walter Strube
Mathias Buettner
Hans-Joachim Rziha
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19639601A external-priority patent/DE19639601A1/de
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of DK0886679T3 publication Critical patent/DK0886679T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
DK97904453T 1996-02-28 1997-02-17 Parakoppevira indeholdende fremmed DNA, fremstilling heraf og deres anvendelse i vacciner DK0886679T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19607458 1996-02-28
DE19639601A DE19639601A1 (de) 1996-02-28 1996-09-26 Parapockenviren, die Fremd-DNA enthalten, ihre Herstellung und ihre Verwendung in Impfstoffen
PCT/EP1997/000729 WO1997032029A1 (de) 1996-02-28 1997-02-17 Parapockenviren, die fremd-dna enthalten, ihre herstellung und ihre verwendung in impfstoffen

Publications (1)

Publication Number Publication Date
DK0886679T3 true DK0886679T3 (da) 2007-09-24

Family

ID=26023280

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97904453T DK0886679T3 (da) 1996-02-28 1997-02-17 Parakoppevira indeholdende fremmed DNA, fremstilling heraf og deres anvendelse i vacciner

Country Status (19)

Country Link
US (1) US6365393B1 (da)
EP (1) EP0886679B1 (da)
JP (1) JP2000507092A (da)
CN (1) CN1217027A (da)
AT (1) ATE364090T1 (da)
AU (1) AU718141B2 (da)
BR (1) BR9707785A (da)
CA (1) CA2247336C (da)
DE (1) DE59712852D1 (da)
DK (1) DK0886679T3 (da)
ES (1) ES2287949T3 (da)
HU (1) HUP9901035A3 (da)
IL (1) IL125797A0 (da)
NO (1) NO983946L (da)
NZ (1) NZ331556A (da)
PL (1) PL190401B1 (da)
SK (1) SK120098A3 (da)
TR (1) TR199801702T2 (da)
WO (1) WO1997032029A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9902438A3 (en) * 1996-03-29 2000-03-28 Bayer Ag Parapoxvirus vectors
US6455283B1 (en) * 1998-03-17 2002-09-24 Genentech, Inc. Nucleic acids encoding vascular endothelial cell growth factor-E (VEGF-E)
NZ511119A (en) * 1998-11-02 2004-04-30 Ludwig Inst Cancer Res Vascular endothelial growth factor-like protein from ORF virus NZ2 binds and activates mammalian VEGF receptor-2
HUP0400479A3 (en) * 2000-07-11 2006-02-28 Bayer Ag Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
US6752995B2 (en) * 2002-04-15 2004-06-22 Board Of Regents, The University Of Texas System Nucleic acid and polypeptide sequences useful as adjuvants
EP1499355A4 (en) 2001-12-07 2005-10-05 Bayer Pharmaceuticals Corp USE OF PARAPOX B2L PROTEIN FOR THE TREATMENT OF CANCER AND THE MODIFICATION OF IMMUNE RESPONSES
CA2573204C (en) * 2004-07-13 2011-09-20 Aicuris Gmbh & Co. Kg Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids
EA201270764A1 (ru) 2010-04-29 2013-06-28 Римзер Фарма Гмбх Парапоксвирус, экспрессирующий vp60 главный белок капсида вируса геморрагического заболевания кроликов
NZ603431A (en) * 2010-05-21 2014-06-27 Zoetis Llc Parapoxvirus vectors containing rabies virus antigen
AU2011281229A1 (en) * 2010-07-20 2013-01-24 Zoetis Llc Parapoxvirus vectors
WO2014015091A2 (en) 2012-07-19 2014-01-23 Zoetis Llc Bovine influenza virus compositions
WO2014018724A1 (en) 2012-07-27 2014-01-30 Zoetis Llc Tick toxin compositions
DE102015111756A1 (de) * 2015-07-20 2017-01-26 Eberhard Karls Universität Tübingen Medizinische Fakultät Rekombinanter Orf-Virus-Vektor
JP6675484B2 (ja) 2015-08-14 2020-04-01 ゾエティス・サービシーズ・エルエルシー マイコプラズマ・ボビス組成物
BR112018069371A2 (pt) 2016-03-21 2019-01-22 South Dakota Board Of Regents construção de ácido nucleico, vetor, vacina ou composição imunogênica, método de entrega de uma vacina, método de produção de uma construção de ácido nucleico e método para conferir imunidade contra um antígeno
JP2021516957A (ja) * 2018-03-07 2021-07-15 トランジェーヌＴｒａｎｓｇｅｎｅ パラポックスウイルスベクター
WO2024062098A1 (en) 2022-09-23 2024-03-28 Transgene Recombinant pseudocowpox virus encoding an interleukin-12

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0758397B1 (en) * 1994-04-29 2005-06-22 Baxter Healthcare S.A. Recombinant poxviruses with foreign polynucleotides in essential regions

Also Published As

Publication number Publication date
TR199801702T2 (xx) 1998-12-21
HUP9901035A2 (hu) 1999-07-28
CN1217027A (zh) 1999-05-19
EP0886679A1 (de) 1998-12-30
WO1997032029A1 (de) 1997-09-04
DE59712852D1 (de) 2007-07-19
JP2000507092A (ja) 2000-06-13
NO983946L (no) 1998-10-22
ATE364090T1 (de) 2007-06-15
EP0886679B1 (de) 2007-06-06
HUP9901035A3 (en) 2001-01-29
NZ331556A (en) 2000-05-26
AU1725797A (en) 1997-09-16
BR9707785A (pt) 1999-07-27
NO983946D0 (no) 1998-08-27
CA2247336A1 (en) 1997-09-04
US6365393B1 (en) 2002-04-02
CA2247336C (en) 2008-06-17
PL190401B1 (pl) 2005-12-30
SK120098A3 (en) 1999-03-12
ES2287949T3 (es) 2007-12-16
IL125797A0 (en) 1999-04-11
PL328870A1 (en) 1999-03-01
AU718141B2 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
DK0886679T3 (da) Parakoppevira indeholdende fremmed DNA, fremstilling heraf og deres anvendelse i vacciner
ATE404220T1 (de) Rekombinierte pockenvirus-tollwut zusammensetzung und kombinierte zusammensetzungen und deren verwendung
BRPI0309631A8 (pt) vacina tetravalente da dengue contendo uma trivial deleção de 30 nucleotídeos na utr-31' dos tipos de dengue 1,2,3 e 4, ou de vírus antigênicos quiméricos da dengue 1,2,3 e 4
BRPI9912663B8 (pt) vacina contra cáncer e polipeptìdeo.
ATE286067T1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
ATE468858T1 (de) Chimäre impfstoffe gegen flaviviren
HK1022719A1 (en) Hamster ef-1 alpha transcriptional regulatory DNA
NO20091761L (no) Viruskapsomervaksine, fremgangsmate for fremstilling samt anvendelse derav
HK1046016B (zh) 疫苗中的重組脫氧核糖核酸膠原
MY150893A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
DK1007686T3 (da) Tuberkulosevaccine
IL181695A0 (en) Methods for cultivating cells and propagating viruses
YU36698A (sh) Parapoks-virusi koji sadrže stranu dnk, njihovo dobijanje i njihova primena u vakcinama
DK0892054T3 (da) Clostridium perfringens-vaccine
ATE424217T1 (de) Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
DE60131975D1 (de) Anwendung des herpes simplex virus glykoproteins-d zur unterdrückung von immunantworten
HUP0001991A2 (hu) Varicella Zoster vírus 63-as géntermékkel szembeni vakcinák
BR9915970A (pt) Vìrus recombinante expressando dna exógenocodificando cd80 felino, ctla-4 felino ou cd86 felinoe usos do mesmo
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
NZ511168A (en) Recombinant CELO virus and CELO virus DNA